---
title: "FET: Conference showcased strong growth, capital returns, and innovation-driven market expansion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297054841.md"
description: "At the Midwest IDEAS Investor Conference, management highlighted strong financial outperformance, robust capital returns, and a growth strategy centered on innovation and market share gains. Guidance for 2026 projects continued revenue and EBITDA growth, with a long-term outlook supported by favorable industry trends.Original document: Forum Energy Technologies, Inc. [FET] Slides Release — Aug. 26 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-26T13:32:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297054841.md)
  - [en](https://longbridge.com/en/news/297054841.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297054841.md)
generator: "portal-rs"
---

# FET: Conference showcased strong growth, capital returns, and innovation-driven market expansion

At the Midwest IDEAS Investor Conference, management highlighted strong financial outperformance, robust capital returns, and a growth strategy centered on innovation and market share gains. Guidance for 2026 projects continued revenue and EBITDA growth, with a long-term outlook supported by favorable industry trends.

Original document: Forum Energy Technologies, Inc. \[FET\] Slides Release — Aug. 26 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [FET.US](https://longbridge.com/en/quote/FET.US.md)

## Related News & Research

- [Forum Energy Technologies Targets $1.6B Revenue by 2030 in Five-Year Growth Plan](https://longbridge.com/en/news/297125197.md)
- [FET: Conference showcased strong growth, capital returns, and ambitious 2030 financial targets](https://longbridge.com/en/news/296244120.md)
- [Why Semtech (SMTC) Is Up 5.7% After Strong Q2 Results And AI-Focused Guidance – And What's Next](https://longbridge.com/en/news/297384085.md)
- [Key facts: Salesforce, Inc. Enhances Anthropic Tie; CRM Near $265](https://longbridge.com/en/news/297393365.md)
- [Cumberland Pharma says ifetroban Phase 2 DMD extension data not ready, pulls August 2026 timing](https://longbridge.com/en/news/297369585.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**